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Abstract 
 
Introduction: The proper regulation of the dentin-pulp complex is intimately related 
through crucial cell-matrix interactions and important bioactive proteins. The proteins 
modulating these interactions are highly expressed during development and implicated in 
tissue repair and regeneration. Within this context, periostin is essential for ECM 
stability, collagen fibrillogenesis, and tissue healing. Periostin is regulated by TGF-β1 in 
response to biomechanical challenges in the PDL. In the scope of the dental pulp, 
periostin expression is reported during development and active dentinogenesis, but has 
yet to be evaluated in dental pulp cells specifically. We hypothesize that periostin is 
expressed by DPCs in response to TGF-β1 and biomechanical stimulation, which has 
implications in dental pulp tissue healing and regeneration. Aims: 1) To determine if 
periostin is expressed by DPCs and to analyze the effect in response to TGF-β1 2) To 
analyze the influence of biomechanical stimulation on the expression of periostin in 
DPCs, 3) To analyze the influence of periostin on the expression of collagen in DPCs. 
Methods: Human dental pulp stem cells (DPSC), human dental pulp fibroblasts (DPF), 
and murine odontoblast-like cells (MDPC-23) were treated with different concentrations 
of TGF-β1 or different regimens of biomechanical stimulation to evaluate periostin 
expression. Cells were also treated with periostin to evaluate the effect on collagen. 
Western blot and ELISA were used to evaluate protein expression. RNA analysis was 
performed by qRT-PCR and a Total Collagen Assay was utilized to evaluate collagen. 
Statistical analysis was performed by Student T-test and ANOVA with Fisher’s LSD test. 
Results: Each cell line expressed periostin protein and mRNA. TGF-β1 supplementation 
resulted in significant changes of periostin expression. Biomechanical stimulation acts to 
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induce changes in periostin expression. No statistically significant differences were found 
in total collagen expression. Conclusions: Expression of periostin was identified in each 
of the dental pulp cell lines, which can be regulated by TGF-β1. DPSC are the most 
responsive cells to stimulation. Continued research and evaluation is needed to determine 
the potential therapeutic ability of periostin within the dental pulp.  
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Chapter 1 - Introduction 
 
The term “Regenerative Endodontics” is defined as a “biologically-based procedure 
designed to physiologically replace damaged tooth structures, including dentin and root 
structures, as well as the dentin-pulp complex” (1). The success of this procedure varies, 
and applying a clinical treatment protocol can be challenging (2). In most cases, this 
procedure is used to manage immature permanent teeth diagnosed with pulpal necrosis 
(2). However, current research is leading to a better understanding of the underlying 
mechanisms of pulpal regeneration and the potential exists to develop a reliable clinical 
protocol that may lead to a consistently successful outcome. Recently, it has been 
proposed that progenitor cell lines in combination with extracellular matrix (ECM) 
bioactive molecules (3), appropriate 3D scaffolds (4, 5), and biomaterials (6) can 
potentially achieve a state of pulpal regeneration (1, 3, 7, 8).  
 
The structure and properties of the dentin-pulp complex are intimately related through 
crucial cell-matrix interactions (9). The proper regulation of these interactions determines 
the adaptive dentin-pulp response by orchestrating the function of important bioactive 
proteins such as growth factors, cytokines, chemokines, and neuropeptides (9-15). The 
proteins modulating these interactions are collectively known as matricellular molecules. 
These molecules act during the repair process by providing a range of signals to the 
constituent cell populations and modulating their phenotype. These molecules are 
expressed at different stages of the healing process with chemo-attractive properties that 
may signal endogenous cells from the pulp proper into the healing zone with the 
expectation of generating tertiary dentin to seal the injury, allowing for soft tissue 
remodeling and repair, maintaining the pulp vitality, or promoting regeneration of pulp-
like tissue (16-20).   
 
In this context, periostin, a matricellular protein has to be considered. Periostin is a 835-
amino acid secreted protein; located on chromosome 13 in humans at map position 
13q13.3 (21). It is a disulfide linked 90-kDa heparin-binding N terminus-glycosylated 
protein (21). It was originally named osteoblast-specific factor-2 (OSF-2), because it was 
discovered in mouse osteoblasts (22), but recently it has been renamed ‘periostin’ due to 
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its heavy localization to periodontal ligament (PDL) fibroblasts and the periosteum of 
mice during development (23). It has been reported in tissues throughout the human body 
which include bone, periosteum, skin and heart tissue; as well as being up-regulated in 
events needing repair, such as in vascular injury, myocardial infarction, muscle injury, 
epithelial ovarian cancer, colorectal cancer, and pulmonary vascular remodeling (21).  
 
Within the oral cavity, periostin is implicated in the maintenance of proper periodontium 
function, integrity and tissue strength (21, 24). It regulates the structural and functional 
characteristics of the PDL (21, 24) in order to withstand the forces of mastication (25) 
and is regulated by TGF-β1 (22, 26) in response to biomechanical challenges (24, 27). 
Periostin is important for ECM homeostasis, remodeling and repair (21, 24) and plays a 
direct role in controlling tissue healing (21, 24, 25, 27). It is considered to be an 
extracellular modulator of cell function via αvβ3 and αvβ5 integrin receptor interactions 
with growth factors and matrix components such as collagen type 1 (26, 28). These 
matricellular interactions have been reported to influence cell behavior (28) as well as 
collagen fibrillogenesis (26, 29, 30).  
 
Although periostin has been identified in numerous tissues throughout the body and 
localized to the PDL, its identification in the dental pulp has been controversial. Early 
evidence, using immunohistochemistry sections of mandibles from mice show heavy 
localized expression of periostin in the PDL only (23, 31). However, more recent studies 
using in situ hybridization of 4 & 10-week old mice mandibles show periostin expression 
throughout the dental pulp, specifically localized at the “pre-odontoblast layer” during 
tooth development (27). Additionally, periostin expression was recently observed 
throughout the pulp proper of fully developed molars in mice one day following cavity 
preparation without pulp exposure using immunohistochemistry sections (32). This 
experimental model suggests that the mechanical stress of drilling acts in the same way as 
mechanical stress of mastication in order to induce periostin expression. Interestingly, 
periostin was identified near the center of the coronal pulp, in proximity to the pulp 
chamber floor and as magnification was increased periostin localization was observed to 
be extracellular. Periostin expression peaked at 24 hours but was detected up to 7 days 
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following the cavity preparation. However, periostin was not identified in the odontoblast 
layer, but there was heavy periostin expression throughout the PDL (32).  
 
The dental pulp is an appropriate tissue to investigate periostin expression since it is a 
loose connective tissue that is highly cellular, vascular and innervated (8). It contains 
multiple cell populations including odontoblasts, fibroblasts and dental pulp stem cells, as 
well as immunocompetent cells including dendritic cells, macrophages, lymphocytes, and 
mast cells (8). The presence of multiple cell populations creates ambiguity as to which, if 
any of these cells express periostin. Odontoblasts are a specialized post-mitotic cell 
responsible for the secretion of dentin (8, 9, 33). They line the inner wall of dentin around 
the periphery of the pulp proper. They have cell bodies that are highly polarized, with 
odontoblastic processes that extend into predentin and dentinal tubules and are able to 
secrete collagen, glycoproteins and calcium salts (8, 9) prior to mineralization of dentin. 
Conversely, dental pulp fibroblasts are located throughout the pulp proper and are 
responsible for the formation and maintenance of the fibrous components and ground 
substances of the connective tissue (8). Fibroblasts synthesize and secrete elements of the 
ECM including collagen, elastin, proteoglycans, glycoproteins, cytokines, growth factors 
and proteinases (8). Fibroblasts are involved in remodeling the connective tissue through 
degradation of collagen and can synthesize molecules for its replacement (8). The main 
difference in collagen between the cell types is the type of collagen secreted by 
odontoblasts normally becomes mineralized (8, 9). Dental pulp stem cells are adult stem 
cells localized to the perivascular region and the cell-rich zone near the odontoblastic 
layer in the pulp proper. These cells are unspecialized with the ability for self-renewal by 
mitosis while in an undifferentiated state. They are multipotent, have the capacity to 
continuously divide, and produce progeny cells that can migrate, differentiate and 
proliferate into a well-differentiated cell line (34). The pulp also contains an ECM, which 
is a structure-less mass that makes up the bulk of loose connective tissue. It is mainly 
composed of collagen I, and III, but contains small amounts of collagen V, VII and XII. It 
also contains other ground substances such as proteoglycan, glycosaminoglycan, non-
collagenous protein, hyaluronic acid, chondroitin sulfate and elastic fibers (8, 9). The 
ECM functions in cell-matrix adhesion and signaling, regulates nutrient diffusion, waste 
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products, and soluble signaling in order to maintain pulpal homeostasis. The ECM also 
contains cytokines, growth factors and inflammatory mediators (8).  
 
The characteristics of the pulp allow for a unique environment as it is enclosed entirely 
by dentin, which forms the dentin-pulp complex. Specifically, dentin is a calcified 
connective tissue that is made up of 10% water, 20% organic material and 70% inorganic 
material (9, 33). The inorganic matrix is composed of hydroxyapatite (9), while the 
organic material consists of about 90% collagen, the majority of which is collagen type I, 
with small traces of collagen type V (9, 33). Collagen fibrils are important to 
dentinogenesis as they provide an organized scaffold for mineralization (33). The non-
collagenous components include dentin phosphoproteins (DPP), dentin matrix protein 
(DMP1), dentin sialoprotein (DSP), Osteopontin (OPN), Osteocalcin, and bone 
sialoprotein (BSP), as well as other proteoglycans, Gla proteins, glycoproteins, growth 
factors and lipids (6). The growth factors included are bone morphogenetic proteins 
(BMP), insulin-like growth factors (IGF), and transforming growth factor beta (TGF-β). 
These non-collagenous components and growth factors play a crucial role in 
dentinogenesis as signaling molecules and regulators of mineralization (8).  
 
The primary functions of the dentin-pulp complex are sensory, nutritional, and protective. 
The dentin-pulp complex is similar to other organs throughout the body, in that it 
possesses innate and adaptive immunity to defend against acute and/or chronic, 
physiologic or pathologic challenges. It responds as a defensive organ and is regulated by 
its ability for pulpal homeostasis and dentinogenesis (6). Generally, any irritation or 
stimulation to the pulp that causes the local release of inflammatory mediators, may result 
in arteriolar vasodilation, increased capillary hydrostatic pressure, leading to increased 
tissue pressure and the potential for localized areas of inflammation (35). In a clinical 
scenario, this sequence of events could be triggered by restorative procedures, dental 
trauma, uncontrolled orthodontics, para-functional forces, abrasion, or dental caries (36). 
The dental pulp’s ability to protect itself is based on the nature and degree of the stress, 
the severity and proximity to the pulp as well as the amount of force placed on the entire 
tooth (15). In general, the potential outcomes from such events include repair and 
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healing, canal obliteration, or complete pulpal necrosis (36). In the event of repair and 
healing, the pathologic challenge must be removed and the neurovascular supply must 
remain intact. This allows for reactionary dentin, a sub-set of tertiary dentin, to be formed 
(9). It is characterized as a response by the original odontoblasts from a mild to moderate 
stress (8, 9). Specifically, an up-regulation of molecular events, initiated by the 
stimulatory effects that release growth factors (TGF-β1, BMP, FGF) from dentin (20,  37, 
38) leads to collagen secretion from existing post-mitotic odontoblasts and subsequent 
mineralization. Alternatively, reparative dentin may be formed when the pathological 
challenge to the pulp is harmful enough to cause cell death to the original odontoblasts 
(20). It is proposed that progenitor cells within the pulp are then signaled to migrate, 
proliferate and differentiate into odontoblast-like cells at the site of injury leading to 
reparative dentin formation (20). Lastly, when a pathological challenge is strong enough 
to cause all cells within the pulp to die, definitive root canal treatment must be 
performed. Necrosis occurs as a result of unmanageable inflammation leading to 
irreversible damage of the pulp. 
 
Under normal conditions, the pulp and PDL are maintained by appropriate mechanical 
loading (27, 39, 40) regulated by TGF-β1 (22-25, 27). It is a regulator of cell growth and 
differentiation, matrix biosynthesis (41, 42), acts as a chemo-attractant and promotes 
dentinogenesis (9). TGF-β1 has been implicated in odontoblast differentiation and dentin 
formation, as well as in the initiation of collagen synthesis (41). TGF-β1 is also known to 
regulate periostin expression and studies have shown there is a dose-dependent increase 
of periostin mRNA by recombinant TGF-β1, in both PDL fibroblasts (24, 43) and pre-
odontoblasts in vitro (27). In this context, there was a 3-fold increase of periostin mRNA 
levels in comparison to the age-matched control mice when stimulated with TGF-β1. 
Furthermore, TGF-β1-null mice displayed no apparent tooth phenotype during normal 
early tooth development. The periostin mRNA level in the TGF-β1-null incisor was 
reduced to 75% of the age-matched control (27).  
 
Application of biomechanical stimulation through cyclic strain has been used to evaluate 
dental pulp cells, and how it effects proliferation (44), production of inflammatory 
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cytokines and collagen (45). It has also been shown to stimulate odontoblastic 
differentiation of dental pulp stem cells (40). The application of cyclic strain has also 
been shown to significantly increase periostin expression in PDL cells (27, 30). In PDL 
cells, periostin mRNA expression is increased by the application of uniaxial cyclic strain 
and the addition of exogenous TGF-β1 (24, 30). The effects of biomechanical stimulation 
on periostin have not been evaluated in dental pulp cells. In general, periostin-null dentin 
in knockout mice show increased mineralization and decreased pulp space under 
mechanical loading. Periostin-null dentin maintains integrity of pulp space under loading-
free conditions (27), but mechanical loading of teeth during mastication produce thick 
secondary dentin, whereas impacted teeth rarely produce secondary dentin (39). 
Additionally, during periostin-null mice knock out experiments the dentin in the incisor 
became thicker and the pulp space gradually became narrower under occlusal loading. 
There was approximately 80% reduction of pulp space compared with that of the age-
matched control. The contralateral loaded-free incisor maintained the integrity of the pulp 
tissue and space.  Interestingly, deletion of periostin also lowers the overall non-collagen 
protein levels and affects the group of small integrin-binding ligand, N-linked 
glycoproteins (SIBLING) in dentin (27). NCP with the ECM are believed to be essential 
for initiation and control of mineralization (9, 41, 46). In periostin-null mice, DSP levels 
were increased, while DMP-1 levels were decreased, suggesting that deletion of periostin 
leads to dramatic changes of SIBLING protein expression profiles, affecting the 
mineralization of dentin and further suggesting that periostin plays a role in regulating 
these proteins (27, 41).  
 
Recruitment of appropriate/adequate cells to the area, stabilization of the matrix, and cell 
proliferation are critical characteristics that influence tissue healing responses and 
homeostasis. An effect on collagen matrix content and quality translate into altered 
biomechanical properties and diminish its capacity to respond to stress. Periostin not only 
influences cell proliferation and migration but has a considerable effect on collagen 
fibrillogenesis during wound healing with a clear effect on tissue strength (29, 30). The 
extracellular matrix, mainly composed of collagen, serves as a scaffold for cellular 
organization (29). The matricellular molecules, such as periostin, serve as mediators 
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and/or signaling molecules to modulate cell activities. Furthermore, periostin’s ability to 
bind collagen and interact with cell surface integrin receptors (αvβ3 and αvβ5) highlights 
its potential role in different cell functions (29). These properties could enhance its 
potential role as a mediator of collagen metabolism by different DPC populations 
relevant in dental pulp homeostasis, repair and regenerative response. 
 
Periostin expression has been reported within the dental pulp at different developmental 
stages (27) and in response to cavity preparation (32). In this system, it has been 
proposed to play a role in collagen synthesis, dentinogenesis and the overall integrity of 
the dental pulp. Collectively this evidence suggests a critical role of periostin, serving as 
a potential modulator of important tissue and cellular functions, regulated by TGF-β1 in 
response to biomechanical challenges. However, it is currently unknown if periostin’s 
role is exclusive to a specific cell type, its expression is induced as a reaction to 
biomechanical stimulation to the pulp and what affect this may have on collagen 
fibrillogenesis within the pulp. 
 
Therefore, our goal is to identify the expression of periostin in different dental pulp 
cell populations, evaluate its ability to be induced by TGF-β1 and biomechanical 
stimulation and to investigate its effect on collagen synthesis.  
 
Hypothesis: Dental pulp cells express periostin, which can be induced by TGF-β1 and 
biomechanical stimulation, leading to increased expression of periostin and changes in 
collagen expression.  
 
Null Hypothesis: Dental pulp cells do not express periostin, nor can periostin expression 
be induced by TGF-β1 or biomechanical stimulation, and does not effect collagen 
expression or dental pulp healing. 
 
The following specific aims will address the hypothesis: 
1) To determine if periostin is expressed by Dental Pulp Cells in vitro and the effect 
of TGF-β1 on its expression 
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2) To analyze the influence of biomechanical stimulation on the expression of 
periostin in different dental pulp cells in vitro 
3) To analyze the effects of periostin on collagen expression by different dental pulp 
cell populations in vitro 
 
  
 17 
Chapter 2 – Materials and Methods 
 
General Cell Culture 
All cell types used in this experiment have been well characterized and were donated by 
Dr. Tatiana Botero (University of Michigan, Ann Arbor, MI, USA). All cell culture tasks 
were carried out under a laminar flow hood. Human dental pulp stem cells (DPSC, 
passage 2) as seen in Figure 1 (47); human dental pulp fibroblasts (DPF, passage 2) as 
seen in Figure 2 (47); and murine MDPC-23 odontoblast-like cells (passage 52) as seen 
in Figure 3 (48), were stored in recovery cell culture freezing medium (Gibco #12648-
010) in liquid nitrogen cryosystem. Cells were thawed in 37°C warm water bath and the 
contents transferred to a T-75 flask (Corning Life Sciences) with 10ml of Dulbecco's 
Modified Eagle's (DMEM (High glucose 1x, Gibco #11995-065)) medium supplemented 
with heat inactivated 10% fetal bovine serum (FBS, Gibco #10082-147), 1% 
penicillin/streptomycin (100 IU/ml penicillin and 100µg/ml streptomycin, Gibco #15140-
122), and 1:1000 fungizone (Gibco #15290-018). Cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. After 24 hours, the media was removed 
by vacuum pipetting and 10ml of fresh media was added. All cells were cultured to reach 
a minimum of 75% confluence. At which point the media was removed by vacuum 
pipetting, the cell layer was washed with 5ml of sterile PBS, and the cells were passed by 
adding 1ml of 0.25% trypsin and 0.05% EDTA to the flask and incubating for 5 minutes. 
When the cells were visibly detached and floating in the media, 5ml of DMEM was 
added to inactivate the Trypsin-EDTA. The contents of the flask were transferred to a 
15ml conical tube (BD Falcon, San Jose, CA) and centrifuged for 5 minutes at 1500 
RPM. The media was removed via vacuum pipetting and the pellet of cells was re-
suspended in 10ml of DMEM. Two 5ml aliquots of re-suspended cells were then placed 
in two T-75 flasks each containing 10ml DMEM and incubated at 37°C in a humidified 
atmosphere of 5% CO2 and 95% air.  
 
Specific Aim 1: To determine if periostin is expressed by Dental Pulp Cells in vitro 
and the effect on TGF-β1 on its expression 
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We analyzed periostin expression levels of DPSC, DPF and MDPC-23 by qRT-PCR, 
Western blotting and ELISA. DPSC and DPF are primary cell lines and were used 
between passages 4 and 7, while MDPC-23 cells are an immortalized cell line. Cells were 
cultured as previously described until a level of 75% confluence was reached. At which 
point the media was removed by vacuum pipetting, the cell layer was washed with 5ml of 
sterile PBS, and the cells were passed by adding 1ml of 0.25% trypsin and 0.05% EDTA 
to the flask and incubating for 5 minutes. When the cells were visibly detached and 
floating in the media, 5ml of DMEM was added to inactivate the Trypsin-EDTA. The 
contents of the flask were transferred to a 15ml conical tube (BD Falcon, San Jose, CA) 
and centrifuged for 5 minutes at 1500 RPM. The media was removed via vacuum 
pipetting and the pellet of cells was re-suspended in 10ml of DMEM. A volume of 15ul 
of re-suspended cells was removed and placed on a Weber hemocytometer (chamber 
depth 0.1mm x 1/400mm) and counted. Total cell count was made to ensure at least 
100,000 cells were placed in 2ml of DMEM in each well of a 6-well plate and sub-
cultured with media changes every 48 hours to reach 75% confluence. At which point, 
cell cultures were divided into groups defined as Group 1: control, cells in DMEM only 
(no TGF-β1 treatment); Group 2: cells treated with 10ng/ml TGF-β1 at time point 0 and 
after 24 hours; and Group 3: cells treated with 10ng/ml TGF-β1 at time point 0 and after 
24 hours. All treatment groups had a total volume of 2ml DMEM at the start and changed 
once at 24 hours. Cell collection occurred at 48 hours. We utilized 10ng/ml and 20ng/ml 
TGF-β1 concentrations due to the reports that periostin expression in PDL cells increases 
with increasing TGF-β1 concentration (23). It is also known that odontoblast cells can be 
stimulated by TGF-β1 (38) and all DPCs express TGF-β1 (49). A pilot study was 
completed using 0ng/ml, 5ng/ml, 10ng/ml, and 20ng/ml TGF-β1 concentrations (41) to 
determine the effects of TGF-β1 on periostin expression. No relevant results were 
identified for the 5ng/ml TGF-β1 groups, and were eliminated from the experimental 
design.  
 
RNA Extraction  
RNA isolation was performed using the PureLink® RNA Mini Kit (Invitrogen). Total 
RNA was isolated from cells by washing the cells twice with 2ml of PBS, and collected 
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in 500ml lysis buffer (Trizol®) by scraping the cells into 1.5mL microcentrifuge tubes. 
The cells collected in Trizol® were incubated for 5 minutes, followed by addition of 
0.1ml chloroform to each microcentrifuge tube. The tubes were shaken vigorously by 
hand for 15 seconds and incubated at room temperature for 2–3 minutes. The tubes were 
then centrifuged at 12,000 Å~ g for 15 minutes at 4oC. After centrifugation, 400µL of the 
upper colorless aqueous phase (containing RNA) was transferred to a fresh RNase–free 
tube. At this point an equal volume 70% ethanol was added and vortexed to obtain a final 
ethanol concentration of 35%. The tubes were then inverted to disperse any visible 
precipitate. A volume of 700µL of each sample was then transferred to a spin cartridge 
and centrifuged at 12,000 Å~ g for 15 seconds at room temperature. The flow-through 
volume was discarded and the spin cartridge was re-inserted into the same collection tube 
(this was repeated until the entire sample was collected). Next, 350µL wash buffer I was 
added to the spin cartridge containing the bound RNA. It was centrifuge at 12,000 Å~ g 
for 15 seconds at room temperature. The flow-through was discarded and the spin 
cartridge was inserted into a new collection tube. At this point the DNase step was 
performed by PureLink® DNase treatment protocol. A total volume of 80µL PureLink® 
DNase mixture (10X DNase I reaction buffer (8µL), re-suspended DNase (3U/µL) 
(10µL), RNase-Free water (62µL) was added directly onto the surface of the spin 
cartridge membrane and incubated at room temperature for 15 minutes. Following this, 
350µL wash buffer I was added to the spin cartridge and centrifuged at 12,000 Å~ g for 
15 seconds at room temperature. The flow-through was discarded and a new collection 
tube was inserted into the spin cartridge. A volume of 500µL wash buffer II with ethanol 
was then added to the spin cartridge. It was centrifuged at 12,000 Å~ g for 15 seconds at 
room temperature. The flow-through was discarded and the spin cartridge was reinserted 
into the same collection tube (repeated once). The spin cartridge was centrifuged at 
12,000 Å~ g for 1 minute to dry the membrane with bound RNA. The collection tube was 
discarded and the spin cartridge was inserted into a recovery tube. At this point, 50µL 
RNase-Free water was added to the center of the spin cartridge and incubated at room 
temperature for 1 minute. The spin cartridge and recovery tube were centrifuged for 1 
minute at ≥12,000 Å~ g at room temperature. Samples were stored as purified RNA in 
RNase-Free water in Eppendorf tubes. To measure the purity of RNA, a 1:25 dilution was 
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made using 4µL of RNA and 96µL of RNase-Free water, placed in a cuvette 
compartment and the absorbance ratio of 260/280 was measured using a DU-640 
Spectrophotometer (Beckman Coulter). A total of 81 samples were stored in -80oC 
freezer until further processing.  
 
Reverse Transcription  
In order to perform qRT-PCR, the RNA samples required reverse transcription (RT) to 
produce complementary DNA (cDNA). Calculations were performed to allow for reverse 
transcription reactions to be performed on an equivalent amount of mRNA for each 
sample (1-2ug). A 50µl RT reaction with 1.0µg total RNA was performed using Taqman 
Reverse Transcription Reagents (Applied Biosystems). The RT reaction was composed 
of a volume of 30.75ul RT Mix (10x Taqman RT Buffer, 25mM MgCl, dNTPs, 
Hexamers, RNase Inhibitor, Multiscribe RT (50U/ul) plus a volume of 19.25ul mix 
RNase-Free water and sample of RNA. The kit included all the necessary components for 
the transcription process. The thermal condition for RT was 25°C for 10 minutes, 48°C 
for 60 minutes and 95°C for 5 minutes and kept at 4°C until the samples were removed 
from the machine. Samples were then stored in -80oC freezer until further processing. 
 
Quantitative Real-Time Polymerase Chain Reaction  
A real-time polymerase chain reaction (qRT-PCR) protocol was performed in triplicate 
on the cDNA samples from each cell line. The qRT-PCR probes for GAPDH, Periostin, 
and Collagen I were performed on a DNA sequence detector, using 20ng cDNA per 
reaction. The conditions for PCR were as follows: 2 minutes at 50°C and 10 minutes at 
95°C; then, 40 cycles each of 15 seconds at 95°C and 1 minute at 60°C on optical 96-well 
plates covered with optical film. Each plate contained triplicates of the test cDNA 
templates and no-template controls for each reaction mix. The 2∆∆Ct method was used to 
calculate gene expression levels relative to GAPDH (50). The Taqman Gene Expression 
Assay IDs (human) are as follow: GAPDH – Hs02758991_g1; POSTN – 
Hs01566748_m1; COL1 – Hs00164004_m1. The Taqman Gene Expression Assay IDs 
(mouse) are as follows: GAPDH – Mm99999915_g1; POSTN – Mm00450111_m1; 
COL1 – Mm01302043_g1. 
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Baseline Messenger RNA Expression  
Baseline expression was evaluated and normalized to the housekeeping gene 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using qRT-PCR with TaqMan 
primer/probes.  
 
Western Blot 
Periostin protein expression was analyzed by western blot. Protein isolation and analysis 
was performed following cell collection. Cells were washed twice with 2ml of PBS, and 
collected in 1ml of PBS by scraping vigorously for 2 minutes into 1.5ml microcentrifuge 
tubes. Cells/PBS mixture was centrifuged at 3,000rpm for 10min at 4ºC to form a pellet. 
The PBS was aspirated by vacuum pipette and the cells were re-suspended in lysis buffer 
(0.1M Tris pH 6.8, 2% SDS, 1% ß-mercaptoethanol, 1:100 protease inhibitor cocktail), 
homogenized in the bullet blender (Next Advance) for 5 minutes, and incubated on ice 
for 30 minutes. The lysates were centrifuged again (12,000 rpm for 10 minutes at 4ºC) 
and protein supernatants collected. Total protein concentration was quantified using the 
micro assay Bradford method and read using the Multiskan Ascent at a wavelength of 
595 nm. Calculations for protein concentration were made and 20µg of each sample was 
added to the appropriate volume of laemmli sample buffer and 2-mercaptoethanol. After 
the mix was prepared, each sample was boiled at 95oC for 5 minutes and 
electrophoretically resolved using 10% SDSPAGE gels (100 V, 2 hours), then 
electroblotted onto polyvinylidene fluoride membranes (PVDF) (90 V, 90 minutes). 
Membranes were blocked (5% milk in TBST pH 7.4, 1 hour), and immuno-probed for 
periostin (0.25ug/ml in 5% milk, rabbit polyclonal to periostin overnight; 1:4,000 goat 
anti-rabbit IgG-HRP, 1 hour) and GAPDH (0.167ug/mL, in 5% milk, 
antihuman/mouse/rat GAPDH overnight; 1:4,000 donkey anti-goat IgG-HRP, 1 hour). 
Immunopositive bands were detected by enhanced chemiluminescence (ECL) and 
autoradiography. Positive controls for periostin included recombinant protein and human 
periodontal ligament cells (hPDL) on passages 4-7, cell culturing was identical to the 
methods previously described (43).  
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ELISA Protein Analysis 
For periostin protein quantification the DuoSet ELISA Development System using 
sandwich ELISA was utilized to measure natural and recombinant human Periostin/OSF-
2 for DPSC and DPF (R&D Systems, DY3548) and mouse Periostin/OSF-2 for MDPC-
23 (R&D Systems, DY2955). Cell culturing was completed as previously described. 
Protein isolation and analysis was performed following cell collection. Cells were washed 
twice with 2.0ml PBS, and collected in 1.0ml PBS by scraping vigorously for 2 minutes 
into 1.5ml microcentrifuge tubes. Cells/PBS mixture was centrifuged at 3,000rpm for 10 
minutes at 4ºC to form a pellet. The PBS was aspirated by vacuum pipette and the cells 
were re-suspended in an ELISA compatible lysis buffer (Invitrogen, FNN0071), 
homogenized in the bullet blender for 5 minutes, and incubated on ice for 30 minutes. 
The lysates were centrifuged again (12,000 RPM for 10 minutes at 4ºC) and protein 
supernatants collected. Specific concentration parameters for each kit were identified for 
the human kit (range: 187 - 12,000pg/ml with no sensitivity listed) and the mouse kit 
(range: 0.156 - 10ng/m with sensitivity: 0.065ng/ml). A 96-well micro-plate was coated 
with 100µL per well of the diluted capture antibody. The plate was sealed and incubated 
overnight at room temperature. After 24 hours, each well was aspirated and forcefully 
washed with 400µL of wash buffer from a squirt bottle; this process was repeated for a 
total of three washes. Following the last wash, aspirating the plate and blotting it against 
clean paper towels to remove all remaining wash buffer. Next, 300µL of blocking buffer 
was added to each well and incubated at room temperature for 1 hour. Following this, the 
aspiration/wash protocol was repeated.  Next, 100µL of each sample or standards in 
reagent diluent was added to each well. The micro-plate was covered with an adhesive 
strip and incubated for 2 hours at room temperature. After incubation, the aspiration/wash 
step was repeated. Next, 100µL of biotinylated detection antibody diluted in reagent 
diluent was added to each well. The micro-plate was again covered with a new adhesive 
strip and incubated for 2 hours at room temperature. The aspiration/wash step was 
repeated. Next, 100µL of the working dilution of Streptavidin-HRP was added to each 
well.  The micro-plate was again covered and incubated for 20 minutes at room 
temperature out of direct light. The aspiration/wash step was then repeated. Next, 100µL 
substrate solution was added to each well and incubated for 20 minutes at room 
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temperature out of direct light. Finally, 50µL of stop solution was added to each well and 
the micro-plate was gently tapped to ensure thorough mixing. A micro-plate reader set to 
450nm was used to determine the optical density of each well immediately after the stop 
solution was added.  
 
Statistical Analysis 
All statistical analyses were completed with the support of the University of Michigan’s 
Center for Statistical Consultation and Research (CSCAR). All data for aim 1 was 
analyzed using one-way ANOVA with Fisher’s LSD post-hoc pairwise comparison 
(P≤0.05). A “lower case letter” will denote statistically significant results between 
compared groups. The analysis was completed using IBM SPSS 21.0 Software (IBM 
Corp, Armonk, New York, United States). At least three independent trials of each 
experiment were done in triplicate to verify reproducibility of results. 
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Specific Aim 2: To analyze the influence of biomechanical stimulation on the 
expression of periostin in different dental pulp cells  
 
Analysis of periostin expression levels in DPSC, DPF and MDPC-23 were evaluated by 
qRT-PCR, Western blot and ELISA. Cells were cultured as previously described until a 
level of 75% confluence was reached. Total cell count was made to ensure (1 × 105 
cells/well) were placed in 2ml of DMEM on flexible-bottomed BioFlexTM Culture Plates 
coated with Collagen I (Flexcell International Corp.) until they reached 75% confluence. 
Media was changed every 48 hours. At which point, cell cultures were subjected to the 
application of continuous or intermittent biomechanical stimulation. The experimental 
groups were run independently, each with a static control (no biomechanical stimulation). 
Cell collection occurred at 48 hours.  
 
Application of continuous biomechanical stimulation: A cyclic mechanical force was 
applied to the dental pulp cells using the cell culture-loading station Flexcell® FX-
5000TM System (Flexcell International Corp., Hillsborough, NC, USA). Fresh media was 
added every 48 hours. To apply the biomechanical stimulation to the cells, the flexible 
bottoms of the plates were deformed to 14% by a computer-operated vacuum system at 
six cycles/minute (i.e., 5 seconds on and 5 seconds off) for 48 hours. Non-stimulated cells 
were used as controls (24, 30, 40). Collection for RNA and total protein were at 48 hours 
after application of the biomechanical stimulation. 
 
Application of intermittent biomechanical stimulation: A cyclic mechanical force was 
applied as previously described for continuous biomechanical stimulation. The 
application parameters were modified as follows: stimulation was applied for 8 hours at 
six cycles/minute (i.e., 5 seconds on and 5 seconds off) and then allowed to rest (no 
stimulation) for 16 hours. Two total cycles were completed. Non-stimulated cells were 
used as controls. RNA and total protein were collected at 48 hours after application of the 
biomechanical stimulation. 
 
RNA Extraction  
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Cells were collected and RNA was purified as previously described.  
 
Reverse Transcription  
Messenger RNA was reverse transcribed to cDNA as previously described using the 
same Taqman mix/probes for GAPDH, Periostin, and Collagen I as previously described. 
 
Quantitative Real-Time Polymerase Chain Reaction  
qRT-PCR was performed as previously described. 
 
Western Blot 
Protein was collected, lysed, and quantified as previously described. Western blot was 
performed as previously described for continuous biomechanical stimulation only. 
Antibodies used were the same as previously described.  Western blot for intermittent 
biomechanical stimulation was not performed since this experimental group was added 
after western blot and ELISA was completed for continuous biomechanical stimulation. 
Since, periostin protein expression was found for the continuous biomechanical 
stimulation group, it was determined to utilize an ELISA technique only for the 
intermittent group.   
 
ELISA Protein Analysis 
ELISA was performed as previously described and the ELISA kits were used according 
to manufacturer’s protocol. 
 
Statistical Analysis for Specific Aim 2 
All statistical analyses were completed with the support of CSCAR. Messenger RNA 
data was analyzed using a Student’s t-test for pairwise comparison between each control 
and type of biomechanical stimulation (continuous or intermittent) (P≤0.05). ELISA data 
was analyzed using ANOVA with Fisher’s LSD post-hoc test (P≤0.05). A “lower case 
letter” will denote statistically significant results between compared groups. The analysis 
was completed using IBM SPSS 21.0 Software (IBM Corp, Armonk, New York, United 
States). At least three independent trials of each experiment were done in triplicate to 
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verify reproducibility of results. 
Specific Aim 3: To analyze the effects of periostin on collagen expression by 
different dental pulp cells  
 
Total Collagen Assay was used to evaluate collagen expression levels in DPSC, DPF and 
MDPC-23 odontoblast-like cells. Cells were cultured as previously described until a level 
of 75% confluence was reached. Total cell count was made to ensure (1 × 105 cells/well) 
were place in 2ml of DMEM in each well of a 6-well plate and sub-cultured with media 
changes every 48 hours to reach 75% confluence. At which point, cell cultures were 
subjected to supplementation with periostin. Group 1: control, cells in DMEM only (no 
supplementation); Group 2: treated with 50ng/ml periostin at time point 0 and 50ng/ml 
periostin at 24 hours; Group 3: treated with 100ng/ml periostin at time point 0 and 
100ng/ml periostin at 24 hours.  
 
Total Collagen Assay 
Cells were washed twice with 2ml of PBS, and collected in 1ml of PBS by scraping 
vigorously for 2 minutes into 1.5ml microcentrifuge tubes. Cells/PBS mixture was 
centrifuged at 3,000rpm for 10 minutes at 4ºC to form a pellet. The PBS was aspirated by 
vacuum pipette and the cells were re-suspended and diluted 1:1 (100ul/100ul) with 12M 
HCl (final concentration 6M HCl). The QuickZyme Total Collagen Kit (QuickZyme 
Biosciences) was completed according to the manufacturer’s protocol. Briefly, tubes 
were incubated for 20 hours at 95oC in a thermoblock. After incubation, tubes were 
centrifuged for 10 minutes at 13,000g and then 35ul of hydrolyzed samples were pipetted 
into appropriate wells of a 96-well micro-plate. Next, 75ul of assay buffer was added to 
each well, the plate was covered and incubated for 20 minutes at room temperature while 
shaking. A volume of 75ul detection agent was then added to each well, the plate was 
sealed and incubated for 60 minutes in a 60oC oven. The micro-plate was then cooled on 
ice to room temperature and the plate was read at 570nm.  
 
Statistical Analysis for Specific Aim 3 
All statistical analyses were completed with the support of CSCAR. All data was 
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analyzed using one-way ANOVA with a Fisher’s LSD post-hoc pairwise comparison 
(P≤0.05). A “lower case letter” will denote statistically significant results between 
compared groups. The analysis was completed using IBM SPSS 21.0 Software (IBM 
Corp, Armonk, New York, United States). Two independent trials of each experiment 
were done in triplicate to verify reproducibility of results. 
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Chapter 3 - Results 
 
Specific Aim 1: To determine if periostin is expressed by Dental Pulp Cells in vitro 
and the effect of TGF-β1 on its expression. 
 
The results for aim 1 are presented for each cell line.  
 
DPSC 
Periostin mRNA expression was evaluated by qRT-PCR in DPSC for 3 experimental 
groups which included the control, 10ng/ml TGF-β1, and 20ng/ml TGF-β1. All results 
were normalized to the housekeeping gene GAPDH. Periostin mRNA was evident in 
each of the 3 experimental groups as seen in Figure 4. There was a statistically significant 
increase in periostin mRNA expression after exposure to 10ng/ml TGF-β1 group 
(p<0.018) for 48 hours. Where as there was a trend for increased periostin mRNA from 
the control group to the 20ng/ml TGF-β1 group (p=0.218), but at lower expression than 
in the 10ng/ml TGF-β1 group (p=0.116). 
 
To demonstrate if DPSC were capable of expressing periostin protein, western blot was 
performed. Immunopositive bands for periostin were observed at approximately 90KDa. 
All samples were normalized to the housekeeping protein GAPDH, which showed 
immunopositive bands at approximately 37KDa. In DPSC, immunopositive bands were 
evident in the 10ng/ml TGF-β1 and 20ng/ml TGF-β1 groups with dose dependent 
increased expression as compares to the control group as seen in Figure 5. 
 
To further evaluate and quantify periostin protein expression, an ELISA was utilized. 
Figure 6 shows periostin protein levels in DPSC at control, 10ng/ml TGF-β1 and 20ng/ml 
TGF-β1 groups. Periostin protein expression in DPSC was evident in all 3 groups. There 
was an overall trend for increased periostin protein expression with increasing 
concentrations of TGF-β1. There was a statistically significant increase in periostin 
protein from the control to 20ng/ml TGF-β1 (p<0.032). There were no statistically 
significant differences, when comparing the control to 10ng/ml TGF-β1  (p=0.097), or 
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comparing the 10ng/ml TGF-β1 group to the 20ng/ml TGF-β1 group (p=0.247). 
 
In summary, DPSC express periostin mRNA and protein and TGF-β1 can be used to 
induce periostin mRNA and protein expression in DPSC. 
 
DPF 
The qRT-PCR for DPF showed periostin mRNA present in each of the 3 experimental 
groups. There were no statistically significant difference between any of the experimental 
groups, but there was a trend for increased periostin mRNA expression as the 
concentration of TGF-β1 increased as seen in Figure 7. Comparing periostin mRNA 
expression from the control group to the 10ng/ml TGF-β1 (p=0.556) and 20ng/ml TGF-
β1 (p=0.255) showed no statistically significant differences. Comparing 10ng/ml TGF-β1 
to 20ng/ml TGF-β1 (p=0.549) was not statistically significant. 
 
To demonstrate if DPF were capable of expressing periostin protein western blotting was 
performed. Immunopositive bands for periostin were evident in the control, 10ng/ml 
TGF-β1 and 20ng/ml TGF-β1 groups. The band intensity was relatively consistent, as 
seen in Figure 8.  
 
To evaluate and quantify periostin protein expression, an ELISA was utilized. Figure 9 
shows periostin protein levels in DPF at control, 10ng/ml TGF-β1 and 20ng/ml TGF-β1 
groups. Periostin protein expression in DPF was evident in all 3 groups. There was an 
overall trend for decreased periostin protein expression with increasing concentrations of 
TGF-β1. There was a statistically significant decrease in periostin protein from the 
control group to the 10ng/ml TGF-β1 group (p<0.028), as well as from the control to 
20ng/ml TGF-β1 (p<0.008) group. There was not a statistically significant difference, 
when comparing 10ng/ml TGF-β1 to the 20ng/ml TGF-β1 (p=0.095). 
 
In summary, DPF express periostin mRNA and protein at control levels. TGF-β1 can be 
used to induce DPF to express increased levels of periostin mRNA but decreased levels 
of periostin protein.  
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MDPC-23 
The qRT-PCR for MDPC-23 shows periostin mRNA present in each of the 3 
experimental groups as seen in Figure 10. There were statistically significant increases of 
periostin mRNA from the control group to 10ng/ml TGF-β1 (p<0.003) and to 20ng/ml 
TGF-β1 (p<0.01). However, there was not a statistically significant difference when 
comparing 10ng/ml TGF-β1 to 20ng/ml TGF-β1 (p=0.158). 
 
To demonstrate if MDPC-23 were capable of expressing periostin protein western blot 
was performed. Immunopositive bands for periostin were evident in the control, 10ng/ml 
TGF-β1 and 20ng/ml TGF-β1 groups. The band intensity was relatively consistent, as 
seen in Figure 11.  
 
To evaluate and quantify periostin protein expression, an ELISA protocol was utilized. 
Figure 12 shows periostin protein levels in MDPC-23 at control, 10ng/ml TGF-β1 and 
20ng/ml TGF-β1 groups. Periostin protein expression in MDPC-23 was evident in all 3 
groups, but at much lower levels than the other 2 cell lines. There was an overall trend for 
increased periostin protein expression with increasing concentrations of TGF-β1. There 
were no statistically significant differences between the following groups: control to the 
10ng/ml TGF-β1 (p<0.452) and 20ng/ml TGF-β1 (p<0.067), as well as comparing 
10ng/ml TGF-β1 to 20ng/ml TGF-β1 (p=0.145). 
 
In summary, MDPC-23 express periostin mRNA and protein at control levels. TGF-β1 
can be used to induce MDPC-23 to express increased levels of periostin mRNA and 
protein.  
 
Figure 13 shows the relative levels of periostin mRNA between the cell lines, but since 
the experiments were completed independently the statistical analysis was not completed 
across cell lines. Figure 14 shows the quantification of periostin protein expression from 
the ELISA protocol, relative to each cell line. Box 1 shows the ELISA mean values for 
each experimental group. 
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Specific Aim 2: To analyze the influence of biomechanical stimulation on the 
expression of periostin in different dental pulp cells  
 
The results for aim 2 are presented for each cell line. Messenger RNA data was analyzed 
using a Student’s t-test for pairwise comparison between each control and type of 
biomechanical stimulation (continuous or intermittent) (P≤0.05). ELISA data was 
analyzed using ANOVA with Fisher’s LSD post-hoc test (P≤0.05). 
 
DPSC 
Periostin mRNA expression was evaluated by qRT-PCR in DPSC for continuous and 
intermittent biomechanical stimulation, which each had their own static control. All 
results were normalized to the housekeeping gene GAPDH. Periostin mRNA was evident 
in each of the experimental groups. There were no statistically significant differences for 
either experimental group against their own static control. However, there was a trend for 
increased periostin mRNA expression from the static control to the continuous 
biomechanical stimulation group (p<0.309) as seen in Figure 15. There was also a trend 
for increased periostin mRNA expression from the static control to the intermittent 
biomechanical stimulation group (p<0.064) as seen in Figure 17.  
 
To demonstrate if DPSC express periostin at the protein level, western blotting was 
performed for the static control and continuous biomechanical stimulation groups only. 
Immunopositive bands for periostin were observed at approximately 90KDa. All samples 
were normalized to the housekeeping protein GAPDH, which showed immunopositive 
bands at approximately 37KDa. Immunopositive bands were evident for the continuous 
biomechanical stimulated group, but were not clearly visible in the static control group as 
seen in Figure 29.  
 
To evaluate and quantify periostin protein expression, ELISA was also utilized. Figure 16 
shows periostin protein levels in DPSC at static control and in the continuous 
biomechanical stimulation group (p<0.380). Figure 18 shows periostin protein levels at 
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static control and in the intermittent biomechanical stimulation group (p<0.250). There 
was an overall trend for increased periostin protein expression in both of the 
biomechanical stimulation groups, but there were no statistically significant differences 
in any of the results. 
 
In summary, DPSC can be induced by biomechanical stimulation to show a trend for 
increased periostin mRNA and protein expression.  
 
DPF 
Periostin mRNA expression was evaluated by qRT-PCR in DPF for continuous and 
intermittent biomechanical stimulation, which each had their own static control. All 
results were normalized to the housekeeping gene GAPDH. Periostin mRNA was evident 
in each of the experimental groups. There were no statistically significant differences for 
either experimental group against their own static control. However, there was a trend for 
increased periostin mRNA expression from the static control to the continuous 
biomechanical stimulation group (p<0.223) as seen in Figure 19. There was no change 
periostin mRNA expression from the static control to the intermittent biomechanical 
stimulation group (p<0.776) as seen in Figure 21.  
 
To demonstrate if DPF express periostin at the protein level, western blotting was 
performed. Immunopositive bands were evident in the static control and continuous 
biomechanical stimulated groups as seen in Figure 29.  
 
To evaluate and quantify periostin protein expression, ELISA was utilized. Figure 20 
shows periostin protein levels at the static control and show a trend for decreased 
periostin in the continuous biomechanical stimulation group (p<0.078). Figure 22 shows 
periostin protein levels at static control and a trend to increase periostin in the intermittent 
biomechanical stimulation group (p<0.055). There were no statistically significant 
differences in any of the results. 
 
In summary, DPF can be induced by continuous biomechanical stimulation and show a 
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trend for increased periostin mRNA, but decreased periostin protein expression. Whereas 
DPF shows a trend for increased periostin mRNA and protein expression when 
intermittently stimulated.  
 
MDPC-23 
Periostin mRNA expression was evaluated by qRT-PCR in MDPC-23 for continuous and 
intermittent biomechanical stimulation, which each had their own static control. All 
results were normalized to the housekeeping gene GAPDH. Periostin mRNA was evident 
in each of the experimental groups. There was a statistically significant decrease in 
periostin mRNA from the static control group to the continuous biomechanical 
stimulation group (p<0.026) as seen in Figure 23. However, there was only a trend for 
decreased periostin expression from the static control to the intermittent biomechanical 
stimulation group (0.216) as seen in Figure 25.  
 
To demonstrate if MDPC-23 express periostin at the protein level, western blotting was 
performed. Immunopositive bands were evident in the static control and continuous 
biomechanically stimulated groups as seen in Figure 29.  
 
To evaluate and quantify periostin protein expression, ELISA was utilized. There was an 
overall trend for decreased periostin protein expression in both experimental groups 
against the static control. Figure 24 shows periostin protein levels at static control and in 
the continuous biomechanical stimulation group (p<0.227), whereas in Figure 26 the 
periostin protein levels are present in the static control and in the intermittent 
biomechanical stimulation group (p<0.078).  
 
In summary, MDPC-23 can be induced by biomechanical stimulation to decrease 
periostin mRNA, and likewise show a trend for decreased periostin protein expression in 
both experimental groups.   
 
Figure 27 shows the relative levels of periostin mRNA between each of the cell lines, but 
since the experiments were completed independently the statistical analysis was not 
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performed. Figure 28 quantifies periostin protein expression from the ELISA technique, 
showing the relative levels of protein. Box 2 shows the ELISA mean values for each 
experimental group. Comparing protein levels across experimental groups the control 
levels of periostin expression are highest in DPF (Figure 30). When the cells are 
intermittently biomechanically stimulated there is a change in the behavior of DPF cells. 
The biomechanical stimulation increases the levels of periostin protein instead of 
decreasing (p<0.005).  
 
Specific Aim 3: To analyze the effects of periostin on collagen expression by 
different dental pulp cell populations  
 
The results for aim 3 are presented for each cell line. All statistical analysis was 
completed using ANOVA with Fisher’s LSD for comparisons (P≤0.05). 
 
DPSC 
Collagen Type I mRNA expression was evaluated by qRT-PCR in DPSC for the same 3 
experimental groups as in aim 1 and the same 2 experimental groups as in aim 2. All 
results were normalized to the housekeeping gene GAPDH. Collagen type I mRNA was 
evident in all 5 experimental groups. There were no statistically significant differences, 
but all results show that collagen type I mRNA expression increased from the control 
group to the experimental group. Figure 32 shows the affect of TGF-β1 on collagen type 
I mRNA.  There was a trend for increase collagen type I mRNA expression from the 
control group to 10ng/ml TGF-β1 (p=0.394) and 20ng/ml TGF-β1 (p=0.183). Comparing 
10ng/ml TGF-β1 to 20ng/ml TGF-β1 (p=0.577) shows an upward trend for collagen type 
I mRNA expression as well. The experimental groups from aim 2 show a trend for 
increased collagen type I mRNA expression from static control to continuous 
biomechanical stimulation (p=0.380) as seen in Figure 33, as well as from static control 
to intermittent biomechanical stimulation (p=0.250) as seen in Figure 34.  
 
To further evaluate collagen expression, a total collagen assay was utilized. The results 
from the total collagen assay may not be reliable since many of the experimental data 
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values were lower than the most diluted standard value. However, the total collagen assay 
was completed 2 times in triplicate for each sample and the same results occurred. The 
total collagen mean values are shown in Box 3. Figure 31 shows the mean total collagen 
levels in the control (1.66ug/ml), in the 50ng/ml periostin (1.42ug/ml) and in the 
100ng/ml periostin (1.36ug/ml) delivery groups. Overall, there was a downward trend in 
total collagen expression from exogenous delivery of periostin.  
 
DPF  
Collagen Type I mRNA expression was evaluated by qRT-PCR in DPF for the same 3 
experimental groups as in aim 1 and the same 2 experimental groups as in aim 2. All 
results were normalized to the housekeeping gene GAPDH. Collagen type I mRNA was 
evident in all 5 experimental groups. There was a statistically significant increase in 
collagen type 1 from control to 20ng/ml TGF-β1 (p=0.009) and from 10ng/ml TGF-β1 to 
20ng/ml TGF-β1 (p=0.027) as seen in Figure 36. There was a trend for increased 
collagen type I mRNA expression from control to 10ng/ml TGF-β1 (p<0.383). There 
were no statistically significant differences in collagen type I expression for aim 2, but 
collagen type I mRNA expression showed a trend for decreased expression in both 
biomechanically stimulated groups. Comparing the experimental groups from aim 2, 
there was a trend for decreased collagen mRNA expression from static control to 
continuous biomechanical stimulation (p=0.660) as seen in Figure 37, as well as from 
static control to intermittent biomechanical stimulation (p=0.391) as seen in Figure 38.  
 
To further evaluate collagen expression, a total collagen assay was utilized. The results 
from the total collagen assay may not be reliable since many of the experimental data 
values were lower than the most diluted standard value. However, the total collagen assay 
was completed 2 times in triplicate for each sample and the same results occurred. Figure 
35 shows the mean total collagen levels in the control (1.74ug/ml), in the 50ng/ml 
periostin (2.27ug/ml) and in the 100ng/ml periostin (1.41ug/ml) groups. There was no 
change in total collagen expression with increasing concentrations of exogenous periostin 
delivery.  
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MDPC-23 
Collagen Type I mRNA expression was evaluated by qRT-PCR in MDPC-23 for the 
same 3 experimental groups as in aim 1 and the same 2 experimental groups as in aim 2. 
All results were normalized to the housekeeping gene GAPDH. Collagen type I mRNA 
was evident in all 5 experimental groups. There were no statistically significant 
differences in any of the experimental groups. In aim 1, control levels to 10ng/ml TGF-
β1 (p=0.154) and 20ng/ml TGF-β1 (p=0.177) showed trends for increased collagen type I 
mRNA expression as seen in Figure 40. Comparing 10ng/ml TGF-β1 to 20ng/ml TGF-β1 
(p=0.922) shows almost no change in collagen type I mRNA expression. Comparing the 
experimental groups in aim 2 show a trend for decreased collagen type I mRNA 
expression from static control to the continuous biomechanical stimulation (p=0.103) as 
seen in Figure 41, and show a trend for increased collagen type I mRNA expression from 
static control to intermittent biomechanical stimulation (p=0.178) as seen in Figure 42.  
 
To further evaluate collagen expression, a total collagen assay was utilized. The results 
from the total collagen assay may not be reliable since many of the experimental data 
values were lower than the most diluted standard value. However, the total collagen assay 
was completed 2 times in triplicate for each sample and the same results occurred. Figure 
39 shows the mean total collagen levels in the control (1.14ug/ml), in the 50ng/ml 
periostin (1.72ug/ml) and in the 100ng/ml periostin (2.71ug/ml) groups. There was an 
overall trend for increased total collagen expression with increasing concentrations of 
exogenous periostin delivery.  
 
Figure 43 represents the effect of TGF-β1 on collagen type I mRNA, with relative levels 
across cell lines. Figure 44, shows the effect from continuous biomechanical stimulation 
on collagen type I mRNA and Figure 45 shows the effect from intermittent 
biomechanical stimulation on collagen type I mRNA across all each cell line.  
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Chapter 4 – Discussion 
 
The potential exists to create a clinical protocol in order to achieve a state of dental pulp 
regeneration. The practicality of this treatment approach would allow for the continued 
development of the entire tooth through soft and hard tissue formation, but could also 
lead to possible solutions for artificial tooth implantation. The difficulty lies in correctly 
identifying the sequence of events that must occur, as well as the appropriate constituents 
that are needed. There have been different mature and progenitor cell lines studied, as 
well as unique ECM bioactive molecules (3), 3D scaffolds (4, 5), and biomaterials (6). 
However, for the first time, the bioactive molecule, periostin, was explored as to how it 
relates to the dentin-pulp complex. Historically, there has been ambiguous localization of 
periostin within dental pulp tissue, and only accurately identified in the periodontal 
ligament (22, 23, 27, 31), as well as other load bearing tissues throughout the body (21). 
Even though periostin has been acknowledged in the pulp proper, previous studies have 
lacked to identify which specific cell types are responsible for its expression.  
 
In this study, we set out to identify the dental pulp cell populations responsible for the 
expression of periostin and suggest a potential role for its expression. Our experimental 
design allowed for the in vitro investigation of 3 cell types, which are located in the 
dental pulp. DPSC, DPF, and MDPC-23 odontoblast-like cells were used since these cells 
compromise the majority of cells present in the heterogenic population of the dental pulp. 
We first examined the capacity of each cell line’s ability to express periostin mRNA and 
protein at control levels and compared those results to periostin mRNA and protein 
expression after the cells were treated with different concentrations of TGF-β1. We 
observed that DPSC, DPF, and MDPC-23 cells each express periostin mRNA at control 
levels and observed significant differences in periostin mRNA in DPSC and MDPC-23 
after TGF-β1 treatment. Periostin protein expression in DPSC also showed significant 
increases after TGF-β1 treatment, and the western blot supports this by showing an 
increase in immunopositive band intensity from the control to the TGF-β1 treatment 
groups. In DPF there were no significant differences in periostin mRNA expression, but 
the ELISA data showed a significant decrease in periostin protein expression in the TGF-
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β1 treatment groups. The MDPC-23 cells also showed periostin protein expression at 
control levels and significant differences when treated with TGF-β1, but overall, at much 
lower levels compared to the DPSC and DPF.  
 
Periostin mRNA and protein were identified in the control groups of DPF and MDPC-23 
cells, but the DPSC only expressed periostin after TGF-β1 treatment. The DPF and 
MDPC-23 cell lines are both well characterized and are terminally differentiated cells, 
whereas DPSC are adult stem cells with the ability to differentiate into cells of 
odontogenic, osteogenic, adipogenic or chondrogenic pathways (34). It was previously 
thought that periostin was only expressed during tooth development (23, 27, 31) and was 
not expressed in the mature pulp. Our results indicate that DPF and MDPC-23 cells have 
the capacity to express periostin without any stimulation, whereas DPSC shows induction 
potential by stimulation with TGF-β1 in order to express periostin. Our results also show 
that the mean values for periostin protein quantification in MDPC-23 were extremely 
low, compared to DPSC or DPF. Recently, periostin was identified in the pulp proper 
after mechanical drilling with peak expression at 24 hours, and visibility up to 7 days 
(32). These results suggested that dental pulp cells express periostin, but did not specify 
the exact cell type. This leads us to speculate that either DPF cells were stimulated to 
express periostin, or DPSC were activated, allowed to differentiate and then expressed 
periostin. Expression was not evident in the odontoblast zone (32). The mechanical 
drilling model supports our findings, since TGF-β1 is expressed as a result from stress to 
the dental pulp. TGF-β1 may also be released during carious demineralization of the 
dentin matrix and be come available in the mediation of dental repair processes (38, 51). 
Its main function is to regulate cell growth and differentiation (38, 41). TGF-β1 usually 
has stimulatory effects for cells of mesenchymal origin and inhibitory effects for cells of 
epithelial or neuroectoderm origin (52). DPSC, DPF and MDPC-23 are all of 
mesenchymal origin and therefore should have stimulatory effects if the treatment 
concentrations are appropriate.  
 
In aim 2 of this experiment, each cell line was biomechanically stimulated in either a 
continuous or intermittent pattern. The continuous group underwent 48 straight hours of 
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14% strain in 6 cycles per minute using the Flexcell® FX-5000TM System. Whereas, the 
intermittent group was stimulated under the same conditions for 8 hours, allowed to rest 
for 16 hours, then stimulated for an additional 8 hours and allowed to rest for 16 more 
hours before collection at 48 hours. The experimental parameters were designed to 
incorporate ideal conditions for periostin expression in hPDL cells (53), as well as being 
a suitable stimulus to DPC (40, 44, 45) Biomechanical stimulation has been shown to 
regulate the expression of periostin and ECM incorporation via TGF-β1 modulation (24, 
25, 27), as well as playing an important role in regulating the function of mesenchymal 
stem cells (54). The type of mechanical stress to dental pulp may vary, but includes fluid 
shear stress, compression, hydrostatic pressure, and uniaxial vertical and horizontal 
stretching (55). There are conditions where the dental pulp is stretched vertically, such as 
during tooth eruption and in orthodontic forces. These forces can also transfer horizontal 
stretch to DPSCs and PDL tissues (56). Previous studies have also suggested that the 
mechanical stress of drilling acts in the same way as mechanical stress of mastication to 
induce periostin expression (32). Continuous biomechanical stimulation was an attempt 
to mimic clinically relevant situations such as chronic dental trauma, uncontrolled 
orthodontic movements, iatrogenic trauma and chronic para-functional forces. The 
intermittent biomechanical stimulation was designed to mimic the nocturnal para-
functional forces of chronic bruxism. Since, biomechanical stimulation is modulated via 
TGF-β1 and we wanted to relate the effects of biomechanical stimulation to that of 
exogenous TGF-β1 delivery. The results from aim 2 show similar trends in periostin 
mRNA and protein expression, for each cell line, as in aim 1. There were no significant 
differences in the DPSC, but both periostin mRNA and protein showed trends for 
increased expression. The DPF cells showed similar results as when treated with TGF-β1, 
but none of the differences were statistically significant. There were trends for increased 
periostin mRNA in both biomechanical groups and increased periostin protein in the 
intermittent group. However, there was a trend for decreased periostin protein in the 
continuous group. The periostin mRNA and protein levels in MDPC-23 cells show an 
overall trend for decreased periostin expression in both types of biomechanical 
stimulation. The only statistically significant result was a decrease in periostin mRNA 
from the static control to continuous biomechanical stimulation group.  
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Biomechanical stimulation activates several intracellular signaling pathways through 
mechanoreceptors (56, 57), thus leading to activation of cells. Studies have shown that 
mechanical stress can regulate the differentiation of DPSC into odontoblasts (40), while 
other studies claim mechanical stress has no effect on differentiation of DPSC (58). Our 
results suggest that biomechanical stimulation may be used to induce expression of 
periostin mRNA and protein. Further evaluation is needed, and potential changes to the 
experimental parameters may be warranted. The parameters for biomechanical 
stimulation were 14% strain in 6 cycles per minute (24). Other investigators have used 
DPCs subjected to 6%, 12%, or 15% strain in 6 cycles per minute for 3-48 hours and 
showed that mechanical stress could stimulate DPCs (45). However, cyclic strain can also 
cause cellular damage and studies have shown that when 15% cyclic strain is applied it 
may lead to cell death (45). Others have shown that a maximum of 15% cyclic strain in 6 
cycles per minute mimics physiological occlusal loading or the effects of moderate 
orthodontic force inducing stress across a PDL with 40kPa. They found that mechanical 
stress up-regulates the mRNA levels of encoding key markers for differentiation of DPC 
to odontoblasts (BSP, OPN, DSPP, DMP-1) (40).  
 
The final aim of this experiment was to identify periostin’s affect on collagen. The 
experimental model included treating each cell line with different concentrations of 
periostin for 48 hours. Collagen fibrillogenesis is a complex, highly regulated, multistep 
process involving many proteins. Collagen is the main structural component of the ECM 
and stabilizes the dental pulp, as well as being the precursor to dentinogenesis. Periostin 
is co-localized and directly binds to Collagen Type I (29). Therefore if periostin is 
expressed in the dental pulp, identifying which cells express it will give us clues as to 
how it affects collagen synthesis and ultimately repair and regeneration. In general, we 
observed no statistically significant differences in total collagen expression. There were 
trends for decreased total collagen expression in DPSC, no change in DPF, and increased 
collagen expression in MDPC-23. TGF-β1 has similar mRNA expression patterns as 
Collagen Type I, and when odontoblasts express TGF-β1 it is sequestered within the 
pulpal ECM where it can participate in repair and homeostasis after pulp injury (37, 41). 
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TGF-β1 has been shown to be an active component of the dental ECM associated with 
regulation of cell growth, differentiation and matrix biosynthesis (59). Therefore we also 
evaluated collagen type I after each of the experimental parameters in aim 1 and 2. 
Collagen Type I mRNA showed trends for increased expression from static control, after 
treatment with different concentrations of TGF-β1, or when biomechanically stimulated 
in DPSC. The DPF cells showed a statistically significant increase in collagen type I 
mRNA after treatment with different concentrations of TGF-β1, but showed trends for 
decreased collagen type I mRNA expression when biomechanically stimulated. The 
MDPC-23 cells showed a trend for increased collagen type I mRNA after treatment with 
different concentrations of TGF-β1 and intermittent biomechanical stimulation, but a 
trend for decreased collagen type I after continuous biomechanical stimulation. There 
were differences in the result from qRT-PCR probing for Collagen Type I and the total 
collagen assay. It is possible that the total collagen assay is not sensitive enough to 
identify specific collagen, therefore not showing a difference in active collagen 
fibrillogenesis. The total collage assay identifies all collagen, including degraded 
collagen and immature collagen. Additionally, exogenous periostin delivery to the cells, 
actually have no effect on influencing or activating its expression potential of collagen.  
 
Overall, DPSC are very responsive to TGF-β1 and have the ability to induce periostin 
expression. Interestingly, the western blot data does not show immunopositive bands for 
the control group in aim 1. In this group, there is no stimulus, so cells may still be in an 
undifferentiated state and lack the ability to express periostin protein. Whereas, when 
DPSC are treated with TGF-β1, the cell may be activated and differentiate into a mature 
cell type that is capable of expressing periostin. DPSC are readily induced to express 
periostin by TGF-β1. The question remains what cell type has the DPSC differentiated 
into, since they have the ability to differentiate into cells of odontogenic, osteogenic, 
adipogenic or chondrogenic pathways (34), Unfortunately, we were not able to identify 
this cell type and there is no way to verify this since no additional evaluations were 
completed. In an active state of differentiation the cells would have to under go 1 full cell 
cycle, which is about 12-16 hours to complete. This would allow enough time for 
maturation of the cellular processes, stimulation to have an affect, and periostin to be 
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expressed at the 48-hour collection. However, if the confluence levels during cell culture 
have already caused differentiation of the DPSC, we may observe that periostin 
expression would be completely dependent on TGF-β1 concentration and activation of 
the cells. TGF-β1 mRNA has been expressed by preodontoblasts and odontoblasts, and is 
also implicated in odontoblast differentiation and dentin formation (41). Therefore, these 
cells could be influenced to take an odontogenic differentiation pathway. (41). Other 
studies have suggested DPSCs physiologically receive mechanical stress by mastication 
and swallowing, thus our results suggest that mechanical stretch may have an essential 
role in the maintenance of DPSCs through increasing the proliferation, while suppressing 
osteogenic differentiation (44). The total collagen assay showed little change in collagen 
expression of DPSC after exogenous periostin delivery. This is an interesting finding, 
since DPSC have been a very responsive cell. It is possible that periostin does not 
regulate or activate DPSC to differentiate, and therefore collagen expression is 
unchanged or even decreased. These cells are not being stimulated or induced, and 
therefore in a stable state, so there is no need for ECM stabilization or collagen 
formation. It would be interesting to see how the cells would respond to biomechanical 
stimulation and then exogenous periostin delivery.  
 
In general, DPF show similar results comparing aim 1 to aim 2. There is a general trend 
for increased periostin mRNA, and decreased periostin protein, except when observing 
the intermittent biomechanical stimulation group for periostin protein which shows 
increased expression. There is much speculation as to why there would be increases in 
mRNA and decreases in protein for both aim 1 and 2. There are several possible 
explanations for this observation. One possibility is that there is a problem post-
translational, not allowing periostin protein to be transcribed. Another possibility is that 
48 hours may be too long of an evaluation period to assess periostin protein expression. If 
the pulp proper expresses periostin that peaks at 24 hours following stimulation (32), we 
can speculate that these cells may have expressed more periostin at 24 hours in order to 
achieve homeostasis, and then periostin expression decreased as time went on. There is 
no doubt that DPF express periostin, as is evident in the control, but the cells may be 
extremely sensitive to TGF-β1 concentrations or biomechanical stimulation. The TGF-β1 
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concentrations and the parameters for 14% strain for a total of 48 hours may be too long 
to stimulate these cells and may be causing damage to the cells. These stimulations to 
DPF may initially be stimulatory as the cells react, but may change to inhibitory after 
some time. By overloading DPF with TGF-β1 it may inhibit and down regulate any 
periostin expression and the homeostatic effects of periostin. These effects may only 
affect periostin post-translational, inhibiting its transcription into protein, and inhibiting 
its secretion extracellular. As TGF-β1 stimulated DPSC to migrate, differentiate and 
proliferate, it may also act to inhibit DPF, allowing the progenitor cells to be activated. 
Interestingly, when the DPF are intermittently biomechanically stimulated, there are no 
changes in periostin mRNA, but a trend for increased periostin protein. The intermittent 
stimulation, may allow the DPF cells to rest and rebound, in order for intracellular 
processes to take place and lead to the expression of periostin protein. The affects on total 
collagen following exogenous periostin delivery to DPF show no change in total 
collagen. The qRT-PCR data from aim 1 shows that collagen type I is significantly up-
regulated following increasing concentrations with TGF-β1, however, collagen type I is 
down-regulated following biomechanical stimulation in both groups.  
 
The MDPC-23 shows periostin protein expression is at much lower levels than the DPSC 
and DPF at control, after treatment from TGF-β1 and biomechanical stimulation. These 
results suggest that MDPC-23 has the ability to express periostin at controls levels, and 
those levels can be influenced when stimulated. However, the levels of periostin 
expression may be at insignificant levels and may not have a clinical application. The 
MDPC-23 cells are odontoblast-like cells and are a terminally differentiated cell line. 
Odontoblasts typically have a more specialized function than the other 2 cell lines in this 
study. The primary function of odontoblasts, regulated by TGF-β1, is dentinogenesis. 
TGF-β1 has been shown to induce secretion of dentin extracellular matrix components 
associated with primary dentinogenesis and to play a role in tertiary or reparative 
dentinogenesis (41). This process includes the synthesis of procollagen fibrils in the 
odontoblasts’ cell bodies, where it aggregates and increases its fibril diameter. The 
procollagen then migrates through the predentin where is will undergo mineralization at 
the mineralization front. This procollagen matures during this migration and will be 
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mineralized there after and incorporated into dentin as tertiary dentin. The majority of 
collagen biosynthesis takes about 2 hours to reach the predentin (33). Simulations to 
MDPC-23 cells react by initiating dentinogenesis and not by regulating ECM stability or 
soft tissue homeostasis. Recent experiments show that during cavity preparation, 
periostin expression is identified in the pulp proper, but not in the odontoblast layer (32). 
This supports our results, and suggests that even though odontoblasts possess the ability 
to express periostin, the in vivo application may be inappropriate since odontoblast 
extracellular secretions are into pre-dentin that ultimately become mineralized. The role 
of periostin to control ECM stability and soft tissue homeostasis during stress may be 
regulated through the expression of a different cell type. Biomechanical stimulation to the 
MDPC-23 cells resulted in down-regulation of periostin expression. It is possible that 
under the influence of mechanical stress, odontoblasts do not express periostin, since they 
function to in hard tissue stabilization. Another explanation is that the biomechanical 
stimulation was too strong and caused the MDPC-23 cells to die. The exogenous 
periostin delivery model shows a trend for increased total collagen expression. This result 
is in line, since periostin is closely related to collagen production and MDPC-23 cells 
primary function is to make collagen as a pre-cursor to mineralization. The influence of 
TGF-β1 to increase collagen type I mRNA is supported since; TGF-β1 is a known 
regulator of dentinogenesis as well.  
 
Proposed Hypothesis 
We hypothesize that biomechanical stimulation of the dental pulp causes localized 
inflammation leading to the release of local mediators, such as TGF-β1. This growth 
factor regulates intracellular and extracellular pathways of dental pulp cells. Periostin is 
expressed by dental pulp fibroblasts throughout the pulp to stabilize the ECM and 
maintain pulpal homeostasis. TGF-β1 also aids in migration, differentiation and 
proliferation of progenitor cells to the area of repair, which also express periostin for 
ECM stabilization prior to collagen formation. Biomechanical stimulation may also 
activate existing odontoblast cells to express periostin at low levels prior to collagen 
formation. Periostin will bind to the collagen fibers in the ECM to increase tissue strength 
and structural stability. It is suggested that periostin expression regulates soft tissue 
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stabilization, and if periostin is down regulated it leads to increased mineralization of the 
pulp space (32). Therefore, this may further confirm that periostin expression by DPSC 
and DPF stabilizes soft tissue formation during the healing phase and prevents soft tissue 
mineralization from occurring. Therefore, periostin’s role is extremely important in 
maintaining the pulp’s homeostasis and structural stability through supporting a 
competent collagen fibrillar system and avoiding complete pulp mineralization due to 
biomechanical forces.  
 
It is speculated that mineralization of dental pulp tissue is feasible, but resisted by a 
negative regulation system. The expression of periostin has been shown to be up-
regulated by cavity preparation, suggesting that the mechanical stress of drilling acts in 
the same manner as other mechanical stressors such as mastication as to induce periostin 
expression (32). Periostin expression was distributed throughout the pulp tissue, and 
seemed to localize between cells rather than inside them. Suggesting that periostin is 
secreted from dental pulp cells and stored in the ECM. Periostin expression is highly up 
regulated during early events of repair in several tissues. Whereas, when faced with 
particularly intense stimuli, such as replantation, this mechanism fails to keep the 
structure of dental pulp tissue intact, leading to canal space obliteration (60). After 
mastication, the incisors of periostin-null mice show massive increase in dentin formation 
and reduction in pulp space compared to age-matched controls. It has also been shown 
that over expression of TGF-β1 has a significant reduction in tooth mineralization and 
defective dentin formation (61). Findings in developing mouse mandibles have suggested 
that periostin serves as adhesive equipment at the sites of cell-to matrix interaction and 
aids against potentially harmful mechanical forces that include occlusal forces and tooth 
eruption (31).  
 
Limitations and Future Directions  
The findings derived from this study contribute to the ongoing effort of describing the 
basic elements involved in pulpal pathogenesis. Current clinical reality reflects the lack 
of a comprehensive understanding of the molecular and cellular events that lead to pulp 
disease, often times limiting treatment only when symptoms appear and normal tissue 
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function is altered or lost. Insights into pulpal pathogenesis incorporate gene, protein, and 
metabolite data into dynamic biologic networks that include disease-initiating and 
progression mechanisms. New evidence is emerging that periostin may play a greater role 
in regulating pulpal homeostasis and preventing complete mineralization of the pulp 
space (32, 41). Ultimately, the data generated may have significant implications to aid in 
the understanding of pulpal biology relevant to cell-matrix dynamics and homeostasis. 
This data adds supporting scientific information that will help capture the dynamic nature 
of extracellular biochemical events involved in the transition between pulpal health, 
disease and the ability to repair and/or regenerate. 
 
The realization is that there are several limitations to extrapolate any findings using an in 
vitro culture methodology to the clinical treatment in humans. These methods are 
challenging, with multiple variables such as cellular behavior, culturing techniques and 
operator error influencing the ability to generate consistent and reproducible results. 
However, in vitro testing is key for understanding and predicting what might happen in 
vivo. It is also an irreplaceable process in order to test different conditions that might 
influence the final in vivo outcomes. Furthermore, future transitions from in vitro to in 
vivo experiments will be looking at effects that are the result of complex systemic, local, 
and environmental interactions. Therefore, understanding the in vitro and in vivo 
experiences is key in order to propose specific ways or concentrations for a possible 
exogenous delivery of periostin. Furthermore, in vivo animal studies could be proposed in 
the future based on the results.  
 
Conclusion 
To conclude, Dental Pulp Cells (DPCs) such as: Stem cells, Fibroblasts and Odontoblast-
like cells are capable of expressing periostin. We have successfully demonstrated that 
periostin mRNA and protein are expressed by all these dental cell populations in vitro. 
We have also confirmed that the expression of periostin is regulated by TGF-β1. In 
addition, biomechanical stimulation may be used as a model to stimulate DPCs in vitro 
with either stimulatory or inhibitory effects. Lastly, exogenous delivery of periostin to 
DPCs yields inconclusive effects on total collagen expression. Overall, DPSCs show the 
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most responsiveness and predictable behavior to stimulus. We propose that activation of 
DPCs through TGF-β1 and biomechanical stimulation may regulate the potential 
therapeutic effects of these cells. Beyond the limits of this study, periostin may have a 
potential therapeutic effect; in order to stabilize the ECM during dentinogenesis, while 
pulpal repair and regeneration is occurring.  
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Tables and Figures 
 
 
 
Figure 1: Phase contrast image of human dental 
pulp stem cells (DPSC) at 100x magnification. 
Cells were grown in Dulbecco's Modified Eagle's 
medium supplemented with heat inactivated 10% 
FBS, 1% penicillin/streptomycin and 1:1000 
fungizone. Cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. 
 
 
 
 
 
 
 
Figure 2: Phase contrast image of human dental 
pulp fibroblast cells (DPF) at 100x magnification. 
Cells were grown in Dulbecco's Modified Eagle's 
medium supplemented with heat inactivated 10% 
FBS, 1% penicillin/streptomycin and 1:1000 
fungizone. Cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. 
 
 
 
 
 
 
 
Figure 3: Phase contrast image of MDPC-23 
odontoblast-like cells at 100x magnification. Cells 
were grown in Dulbecco's Modified Eagle's 
medium supplemented with heat inactivated 10% 
FBS, 1% penicillin/streptomycin and 1:1000 
fungizone. Cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. 
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Figure 4: TGF-β1 Effect on Periostin mRNA in DPSC after 48 hours. Statistically 
significant difference from control to 10ng/ml TGF-β1 [a:(P=0.018) Fisher’s LSD] 
 
  
Figure 5: Western Blot for periostin protein in DPSC; GAPDH as housekeeping protein; 
comparing control to treatment with TGF-β1 after 48 hours. Molecular Weight (MW) and 
hPDL cells used for positive control.  
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Figure 4: TGF-β1 Effect on Periostin mRNA in 
DPSC 
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
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Figure 6: TGF-β1 Effect on Periostin Protein in DPSC after 48 hours. Statistically 
significant difference from control to 20ng/ml TGF-β1 [a:(P=0.032) Fisher’s LSD] 
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Figure 6: TGF-β1 Effect on Periostin Protein in 
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Figure 7: TGF-β1 Effect on Periostin mRNA in DPF after 48 hours. No statistically 
significant differences between groups [(P>0.05) Fisher’s LSD] 
  
Figure 8: Western Blot for periostin protein in DPF; GAPDH as housekeeping protein; 
comparing control to treatment with TGF-β1 after 48 hours. Molecular Weight (MW) and 
hPDL cells used for positive control. 
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Figure 7: TGF-β1 Effect on Periostin mRNA in 
DPF 
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
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Figure 9: TGF-β1 Effect on Periostin Protein in DPF after 48 hours. Statistically 
significant difference from control to 10ng/ml TGF-β1 and 20ng/ml TGF-β1 
[a:(P=0.028), b:(P=0.008) Fisher’s LSD] 
  
0.00	  
0.50	  
1.00	  
1.50	  
2.00	  
2.50	  
3.00	  
3.50	  
P
er
io
st
in
 (n
g/
m
l) 
Figure 9: TGF-β1 Effect on Periostin Protein in 
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Figure 10: TGF-β1 Effect on Periostin mRNA in MDPC-23 after 48 hours. 
Statistically significant difference from control to 10ng/ml TGF-β1 and 20ng/ml TGF-β1 
[a:(P=0.003), b:(P=0.001) Fisher’s LSD] 
 
 
  
Figure 11: Western Blot for periostin protein in MDPC-23; GAPDH as housekeeping 
protein; comparing control to treatment with TGF-β1 after 48 hours. Molecular Weight 
(MW) and hPDL cells used for positive control. 
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Figure 10: TGF-β1 Effect on Periostin mRNA in 
MDPC-23 
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Figure 12: TGF-β1 Effect on Periostin Protein in MDPC-23 after 48 hours. No 
statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
 
Figure 13: TGF-β1 Effect on Periostin mRNA in DPSC, DPF, & MDPC-23 after 48 
hours. Statistically significant differences [a:(P=0.018); b:(P=0.003); c:(P=0.001) 
Fisher’s LSD] 
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Figure 12: TGF-β1 Effect on Periostin Protein in 
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Figure 13: TGF-β1 Effect on Periostin mRNA in DPSC, DPF, & 
MDPC-23  
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Figure 14: TGF-β1 Effect on Periostin Protein (ELISA) in DPSC, DPF, & MDPC-23 
after 48 hours. Statistically significant differences [a:(P=0.032); b:(P=0.028); 
c:(P=0.008) Fisher’s LSD] 
 
Figure 15: Continuous Biomechanical Stimulation on Periostin mRNA in DPSC 
after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student’s t-test] 
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Figure 14: TGF-β1 Effect on Periostin Protein (ELISA) in 
DPSC, DPF, & MDPC-23 
Control TGF-β1 10 ng/ml TGF-β1 20 ng/ml 
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Figure 15: Continuous Biomechanical 
Stimulation on Periostin mRNA in DPSC 
Control Continuous Stimulation  
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Figure 16: Continuous Biomechanical Stimulation on Periostin Protein in DPSC 
after 48 hours. No statistically significant differences between groups [(P>0.05) Fisher’s 
LSD] 
 
Figure 17: Intermittent Biomechanical Stimulation on Periostin mRNA in DPSC 
after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student’s t-test] 
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Figure 16: Continuous Biomechanical 
Stimulation on Periostin Protein in DPSC (ELISA) 
Control Continuous Stimulation 
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Figure 17: Intermittent Biomechanical 
Stimulation on Periostin mRNA in DPSC 
Control Intermittent Stimulation 
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Figure 18: Intermittent Biomechanical Stimulation on Periostin Protein in DPSC 
after 48 hours. No statistically significant differences between groups [(P>0.05) Fisher’s 
LSD] 
 
Figure 19: Continuous Biomechanical Stimulation on Periostin mRNA in DPF after 
48 hours. No statistically significant differences between groups [(P>0.05) Student’s t-
test] 
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Figure 18: Intermittent Biomechanical 
Stimulation on Periostin Protein in DPSC (ELISA) 
Control Intermittent Stimulation 
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Figure 19: Continuous Biomechanical 
Stimulation on Periostin mRNA in DPF 
Control Continuous Stimulation  
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Figure 20: Continuous Biomechanical Stimulation on Periostin Protein in DPF after 
48 hours. No statistically significant differences between groups [(P>0.05) Fisher’s 
LSD] 
 
Figure 21: Intermittent Biomechanical Stimulation on Periostin mRNA in DPF after 
48 hours. No statistically significant differences between groups [(P>0.05) Student’s t-
test] 
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Figure 20: Continuous Biomechanical 
Stimulation on Periostin Protein in DPF (ELISA) 
Control Continuous Stimulation 
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Figure 21: Intermittent Biomechanical 
Stimulation on Periostin mRNA in DPF 
Control Intermittent Stimulation 
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Figure 22: Intermittent Biomechanical Stimulation on Periostin Protein in DPF 
after 48 hours. No statistically significant differences between groups [(P>0.05) Fisher’s 
LSD] 
 
 
Figure 23: Continuous Biomechanical Stimulation on Periostin mRNA in MDPC-23 
after 48 hours. Statistically significant differences between groups [a:(P=0.026) 
Student’s t-test] 
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Figure 22: Intermittent Biomechanical 
Stimulation on Periostin Protein in DPF (ELISA) 
Control Intermittent Stimulation 
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Figure 23: Continuous Biomechanical 
Stimulation on Periostin mRNA in MDPC-23 
Control Continuous Stimulation  
a	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Figure 24: Continuous Biomechanical Stimulation on Periostin Protein in MDPC-23 
after 48 hours. No statistically significant differences between groups [(P>0.05) Fisher’s 
LSD] 
 
Figure 25: Intermittent Biomechanical Stimulation on Periostin mRNA in MDPC-
23 after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student’s t-test] 
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Figure 24: Continuous Biomechanical 
Stimulation on Periostin Protein in MDPC-23 
(ELISA) 
Control Continuous Stimulation 
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Figure 25: Intermittent Biomechanical 
Stimulation on Periostin mRNA in MDPC-23 
Control Intermittent Stimulation 
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Figure 26: Intermittent Biomechanical Stimulation on Periostin Protein in MDPC-
23 after 48 hours. No statistically significant differences between groups [(P>0.05) 
Fisher’s LSD] 
Figure 27: Continuous Biomechanical Stimulation Effect on Periostin mRNA in 
DPSC, DPF, & MDPC-23 after 48 hours. Statistically significant difference 
[a:(P=0.026) Student’s t-test] 
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Figure 26: Intermittent Biomechanical 
Stimulation on Periostin Protein in MDPC-23 
(ELISA) 
Control Intermittent Stimulation 
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Figure 27: Continuous Biomechanical Stimulation Effect on 
Periostin mRNA 
Control Continuous Stimulation 
a
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Figure 28: Intermittent Biomechanical Stimulation Effect on Periostin mRNA in 
DPSC, DPF, & MDPC-23 after 48 hours. No statistically significant findings between 
groups [(P>0.05) Student’s t-test] 
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Figure 28: Intermittent Biomechanical Stimulation Effect 
on Periostin mRNA 
Control Intermittent Stimulation 
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Figure 29: Western Blot for DPSC, DPF, & MDPC-23 probing for periostin, GAPDH as 
housekeeping protein; comparing at baseline levels to biomechanical stimulation after 48 
hours. Molecular Weight (MW) and hPDL cells used for positive control.  
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Figure 30: Biomechanical Stimulation Effect on Periostin Protein in DPSC, DPF, 
and MDPC-23 (ELISA) after 48 hours. Statistically significant differences 
[a:(P=0.005); b:(P=0.012) Fisher’s LSD] 
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Figure 30: Biomechanical Stimulation Effect on Periostin 
Protein in DPSC, DPF, and MDPC-23 (ELISA)  
Control Continuous Intermittent 
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Figure 31: Exogenous Periostin Affect on Total Collagen in DPSC after 48 hours. No 
statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
 
Figure 32: TGF-β1 Affect on Collagen I mRNA in DPSC after 48 hours. No 
statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
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Figure 31: Exogenous Periostin Affect on Total 
Collagen in DPSC 
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Figure 32: TGF-β1 Affect on Collagen I mRNA in 
DPSC 
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
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Figure 33: Continuous Biomechanical Stimulation Affect on Collagen I mRNA in 
DPSC after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student T-test] 
 
 
Figure 34: Intermittent Biomechanical Stimulation Affect on Collagen I mRNA in 
DPSC after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student T-test] 
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Figure 33: Continuous Biomechanical 
Stimulation Affect on Collagen I mRNA in DPSC 
Control Continuous Stimulation  
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Figure 34: Intermittent Biomechanical 
Stimulation Affect on Collagen I mRNA in DPSC 
Control Intermittent Stimulation 
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Figure 35: Exogenous Periostin Affect on Total Collagen in DPF after 48 hours. No 
statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
 
Figure 36: TGF-β1 Affect on Collagen I mRNA in DPF after 48 hours. Statistically 
significant differences [a:(P=0.009), b:(P=0.027); ANOVA LSD] 
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Figure 35: Exogenous Periostin Affect on Total 
Collagen in hDPF 
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Figure 36: TGF-β1 Affect on Collagen I mRNA in 
DPF  
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
a	  
b	  
a,	  b	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Figure 37: Continuous Biomechanical Stimulation Affect on Collagen I mRNA in 
DPF after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student T-test] 
 
Figure 38: Intermittent Biomechanical Stimulation Affect on Collagen I mRNA in 
DPF after 48 hours. No statistically significant differences between groups [(P>0.05) 
Student T-test] 
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Figure 37: Continuous Biomechanical 
Stimulation Affect on Collagen I mRNA in DPF 
Control Continuous Stimulation  
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Figure 38: Intermittent Biomechanical 
Stimulation Affect on Collagen I mRNA in DPF 
Control Intermittent Stimulation 
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Figure 39: Exogenous Periostin Affect on Total Collagen in MDPC-23 after 48 
hours. No statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
 
Figure 40: TGF-β1 Affect on Collagen I mRNA in MDPC-23 after 48 hours. No 
statistically significant differences between groups [(P>0.05) Fisher’s LSD] 
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Figure 39: Exogenous Periostin Affect on Total 
Collagen in MDPC-23 
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Figure 40: TGF-β1 Affect on Collagen I mRNA in 
MDPC-23 
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
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Figure 41: Continuous Biomechanical Stimulation Affect on Collagen I mRNA in 
MDPC-23 after 48 hours. No statistically significant differences between groups 
[(P>0.05) Student T-test] 
 
Figure 42: Intermittent Biomechanical Stimulation Affect on Collagen I mRNA in 
MDPC-23 after 48 hours. No statistically significant differences between groups 
[(P>0.05) Student T-test] 
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Figure 41: Continuous Biomechanical 
Stimulation Affect on Collagen I mRNA in 
MDPC-23 
Control Continuous Stimulation  
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Figure 42: Intermittent Biomechanical 
Stimulation Affect on Collagen I mRNA in 
MDPC-23 
Control Intermittent Stimulation 
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Figure 43: TGF-β1 Affect on Collagen I mRNA in DPSC, DPF & MDPC-23 after 48 
hours. Statistically significant differences [a:(P=0.009), b:(P=0.027); ANOVA LSD]
Figure 44: Continuous Biomechanical Stimulation Effect on Collagen I mRNA in 
DPSC, DPF, & MDPC-23 after 48 hours. No statistically significant differences 
between groups [(P>0.05) Student T-test] 
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Figure 43: TGF-β1 Affect on Collagen I mRNA in 
DPSC, DPF & MDPC-23 
Control 10ng/ml TGF-β1 20ng/ml TGF-β1 
a b
a,	  b	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Figure 44: Continuous Biomechanical Stimulation Effect on 
Collagen I mRNA in DPSC, DPF, & MDPC-23 
Control Continuous Stimulation 
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Figure 45: Intermittent Biomechanical Stimulation Effect on Collagen I mRNA in 
DPSC, DPF, & MDPC-23 after 48 hours. No statistically significant differences 
between groups [(P>0.05) Student T-test] 
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Figure 45: Intermittent Biomechanical Stimulation Effect on 
Collagen I mRNA in DPSC, DPF, & MDPC-23 
Control Intermittent Stimulation 
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Box	  1:	  ELISA	  Mean	  Values	  -­‐	  TGF-­‐β1	  Effect	  on	  Periostin	  Protein	  (ng/ml)	  
	  	   DPSC	   	  	   DPF	   	  	   MDPC-­‐23	  
	  	   MEAN	   SEM	  
	  
MEAN	   SEM	  
	  
MEAN	   SEM	  
Control	   1.5081	   0.0965	  
	  
2.8027	   0.2739	  
	  
0.0972	   0.0000	  
10ng/ml	  TGF-­‐β1	   2.9647	   0.6324	  
	  
1.6725	   0.1811	  
	  
0.1022	   0.0032	  
20ng/ml	  TGF-­‐β1	   3.8412	   0.3871	   	  	   0.9958	   0.1041	   	  	   0.1134	   0.0063	  
 
 
 
Box	  2:	  ELISA	  Mean	  Values	  -­‐	  Biomechanical	  Stimulation	  Effect	  on	  Periostin	  Protein	  (ng/ml)	  
	  	   DPSC	   	  	   DPF	   	  	   MDPC-­‐23	  
	  	   MEAN	   SEM	  
	  
MEAN	   SEM	  
	  
MEAN	   SEM	  
Control	   1.7352	   0.1519	  
	  
2.2912	   0.1944	  
	  
0.1143	   0.0055	  
Continuous	  Stimulation	   1.6848	   0.4402	  
	  
1.7261	   0.1542	  
	  
0.1225	   0.0040	  
Intermittent	  Stimulation	   1.9864	   0.0782	   	  	   2.9182	   0.1729	   	  	   0.1005	   0.0037	  
 
 
 
Box	  3:	  Total	  Collagen	  Assay	  Mean	  Values	  -­‐	  Periostin	  Affect	  on	  Total	  Collagen	  (ug/ml)	  
	  	   DPSC	   	  	   DPF	   	  	   MDPC-­‐23	  
	  	   MEAN	   SEM	  
	  
MEAN	   SEM	  
	  
MEAN	   SEM	  
Control	   1.6665	   0.2649	  
	  
1.7414	   0.3782	  
	  
1.1368	   0.4190	  
50ng/ml	  Periostin	   1.4163	   0.3163	  
	  
2.2708	   0.9169	  
	  
1.7216	   1.0546	  
100ng/ml	  Periostin	   1.3629	   0.1065	   	  	   1.4069	   0.1085	   	  	   2.7082	   1.4826	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